首页> 外国专利> METHOD TO PREDICT THE NEED FOR THERAPY OF PATIENTS SUFFERING FROM CHRONIC LYMPHOCYTIC LEUKEMIA

METHOD TO PREDICT THE NEED FOR THERAPY OF PATIENTS SUFFERING FROM CHRONIC LYMPHOCYTIC LEUKEMIA

机译:预测慢性淋巴细胞性白血病患者治疗需求的方法

摘要

The present invention relates to the prediction of the need for therapy of patients suffering from chronic lymphocytic leukemia (CLL). Here, the inventors developed a procedure to investigate whether CD8+T cell compartment is sculptured by disease progression and to evaluate the prognostic value of this compartment shaping, by applying a combination of statistical tools to flow cytometry data. Their results reveal that the CD8+T cell phenotype is imprinted by tumor progression in CLL patients. They identify a phenotypic signature combining at least 6 unrelated markers that describes the evolution towards therapy within 6 months after phenotyping in fresh whole blood samples, which was never done before and which allow the stratification of patients. The invention relates to a method for identifying phenotypical signatures within CD8+ lymphocytes to predict the need for therapy of a patient suffering from CLL comprising several steps.
机译:本发明涉及对患有慢性淋巴细胞性白血病(CLL)的患者的治疗需求的预测。在此,发明人开发了一种程序,该程序通过将统计工具应用于流式细胞术数据来研究疾病进展是否能雕刻出CD8 + T细胞区室并评估该区室成形的预后价值。他们的研究结果表明,CLL患者的肿瘤进展会显示出CD8 + T细胞表型。他们确定了结合至少6个无关标志物的表型特征,这些标志物描述了在新鲜全血样本中进行表型化后6个月内向治疗的发展,这是以前从未做过的,并且允许患者分层。本发明涉及一种用于鉴定CD8 +淋巴细胞内的表型特征以预测对患有CLL的患者的治疗需求的方法,该方法包括几个步骤。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号